Volume 12, Number 6—June 2006
Research
Co-infections of Adenovirus Species in Previously Vaccinated Patients
Table 2
Original designation† | Vaccination date | Microarray‡ | Adenovirus Consensus kit | PCR determination‡ |
|
---|---|---|---|---|---|
Positive | Negative | ||||
7151.AV5.V.98.FJ | 5 Nov 1997 | C, 21 | C, B1 | 5, 21 | B2 |
7137.AV4.V.97.FJ | 1 Dec 1997 | 4, C, B2 | E | 4, 1 | |
7274.AV4.V.98.FJ | 11 Feb 1998 | 4, 21, C, B2 | E, B1, B2 | 4, 21, B2 | C |
7307.AV5.V.98.FJ | 9 Feb 1998 | C, 21 | C | C | 21 |
7333.AV4.V.98.FJ | 25 Mar 1998 | 4, C, B2 | E | 4, 1, 5, B2 | |
4185.AV4.V.97.FLW | 24 Mar 1997 | 4, C, B2 | E, B2, F, B1 | 4, B2 | C |
4476.AV4.V.97.FLW | 24 Oct 1997 | 4, C, B2 | E, B2, F, B1 | 4, 5, B2 | |
79.AV4.V.96.GL | 7 Oct 1996 | 4, C, 7 | E | 4, C, B2 | 7 |
141.AV7.V.96.GL | 12 Nov 1996 | 7, 4, 3 | B1, B2, E | 7, 4, B2 | 3 |
275.AV4.V.97.GL | 31 Jan 1997 | 4, C, 7 | E, B2, F, B1 | 4, C, B2 | 7 |
1212.AV7.V.97.GL | 29 Sep 1997 | 7, 4, 3 | B1, E, F | 7, 4, 3, F | |
1108.AV7.V..97.GL | 8 Oct 1997 | 7, 4, C, 3 | B1, E, F | 7, 4, C | 3 |
1122.AV7.V.97.GL | 8 Oct 1997 | 7, C, 3 | B1 | 7, C | 3 |
1150.AV7.V.97.GL | 8 Oct 1997 | 7, 4, 3 | B1, E, F | 7, 3, F | 4 |
1152.AV7.V.97.GL | 8 Oct 1997 | 7, 4, 3 | B1 | 7, 4 | 3 |
1186.AV7.V.97.GL | 8 Oct 1997 | 7, 4 | B1, E, F | 7 | 4 |
1251.AV7.V.97.GL | 8 Oct 1997 | 7, 4, 3 | B1, E, F | 7 | 4, 3 |
1275.AV7.V.97.GL | 8 Oct 1997 | 7, 4, 3 | B1, E | 7, 4, 3 | |
1302.AV7.V.97.GL | 8 Oct 1997 | 7, 4, 3 | B1, E, F | 7, 4 | 3 |
1649.AV7.V.98.GL | 13 Jan 1998 | 7, 3, 4 | B1 | 7, 3 | 4 |
1856.AV5.V.98.GL | 25 Mar 1998 | C, 7 | C | C | 7 |
60406.AV7.99.FB | 7 | B1 | 7 | ||
60673.AV4.00.FB | 4, C | E | 4 | C | |
60691.AV4.00.FB | 4, C | E | 4 | C | |
60697.AV4.00.FB | 4, C | E | 4, 1 | ||
60708.AV4.00.FB | 4, C | E | 4 | C | |
60716.AV4.00.FB | 4, C | E | 4 | C | |
CHPPM2.AV4.00.FB | 4, C | E | 4 | C | |
CHPPM9.AV4.00.FB | 4, C | E | 4 | C | |
CHPPM13.AV4.00.FB | 4, C | E | 4 | C | |
CHPPM29.AV4.00.FB | 4, C | E | 4 | C | |
CHPPM44.AV4.00.FB | 4, C | E | 4 | C | |
7372.AV5.98.FJ | C, 7 | C | C | 7 | |
40098.AV4.98.FJ | 4 | E, F | 4, F | ||
40160.AV4.98.FJ | 4 | E | 4 | ||
40183.AV4.98.FJ | 4 | E | 4 | ||
40781.AV4.99.FJ | 4, C | E, B2 | 4, B2 | C | |
40844.AV4.99.FJ | 4, C | E, B2 | 4, B2 | C | |
41059.AV4.99.FJ | 4, C | E, B2, F | 4, C, B2, F | ||
10060.AV4.98.GL | 4, C, B2 | E, B2 | 4, B2 | C | |
10190.AV4.98.GL | 4 | E | 4 | ||
10206.AV4.98.GL | 4, C, B2 | E, B2 | 4, B2 | C | |
10213.AV4.98.GL | 4, C, B2 | E, B2, F | 4, B2 | ||
10257.AV4.98.GL | 4, B2 | E | 4, B2 | ||
10258.AV4.98.GL | 4 | E | 4 | ||
10756.AV4.00.GL | 4 | E | 4 | ||
50108.AV4.00.LAC | 4, B2 | E | 4, B2 | ||
20044.AV4.98.MCRD | 4, C, 7, 3 | E | 4, 1, B2 | 7, 3 | |
20139.AV4.98.MCRD | 4 | E | 4 | ||
20142.AV4.98.MCRD | 4 | E | 4 | ||
20143.AV4.98.MCRD | 4, C, B2 | E, B2, F | 4, C, B2, F | ||
20145.AV4.98.MCRD | 4, C, B2 | E, B2, F | 4, B2 | C |
*PCR, polymerase chain reaction. Species and serotype are listed in order of predominance. Letters or numbers in boldface indicate weak positives.
†Acquisition number, serotype, isolation year, and isolation location.
‡Results are listed as serotypes or species. Species B1 includes serotypes 3, 7, 16, 21; species C includes serotypes 1, 2, 5, 6; and species E includes serotype 4.
1These authors contributed equally to this article.
2The members of the Epidemic Outbreak Surveillance Consortium are Peter F. Demitry, Theresa Lynn Difato, Robb K. Rowley, Clark Tibbetts, Eric H. Hanson, Rosana R. Holliday, Curtis White, David A. Stenger, Donald Seto, Elizabeth A. Walter, Jerry Diao, Brian K. Agan, Kevin Russell, David Metzgar, Gary J.Vora, Baochuan Lin, Dzung Thach, Jing Su, Chris Olsen, Dong Xia, John Gomez, John McGraw, Linda Canas, Margaret Jesse, Mi Ha Yuen, Robert Crawford, Sue A. Worthy, Sue Ditty, John McGraw, Michael Jenkins, Zheng Wang, Cheryl J. James, Kathy Ward, Kenya Grant, and Kindra Nix.